Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Multi Cap Value Alphadex First Trust | FAB | 6. mai 2024 | 80.24 | +0.90 |
Multi Ways Holdings Limited | MWG | 6. mai 2024 | 0.31 | -7.66 |
MultiPlan A | MPLN | 6. mai 2024 | 0.67 | +1.86 |
MultiSensor AI | MSAI | 6. mai 2024 | 2.69 | -1.82 |
Mural Oncology | MURA | 6. mai 2024 | 3.78 | -1.31 |
Murano Global Investments | MRNO | 6. mai 2024 | 8.72 | 0.00 |
Murphy Oil | MUR | 6. mai 2024 | 44.48 | +0.75 |
Murphy USA | MUSA | 6. mai 2024 | 402.56 | +2.58 |
Mustang Bio | MBIO | 6. mai 2024 | 0.30 | -5.29 |
MV Oil Royalty Trust | MVO | 6. mai 2024 | 9.87 | -0.10 |
MVB Financial | MVBF | 6. mai 2024 | 18.67 | +0.81 |
My Size | MYSZ | 6. mai 2024 | 4.78 | +14.35 |
Myers Industries | MYE | 6. mai 2024 | 22.99 | +0.75 |
MyMD Pharmaceuticals | MYMD | 6. mai 2024 | 3.06 | -8.11 |
Mynaric ADR | MYNA | 6. mai 2024 | 5.48 | +15.61 |
Myomo | MYO | 6. mai 2024 | 3.94 | +4.79 |
MYR Group | MYRG | 6. mai 2024 | 152.42 | +5.91 |
Myriad Genetics | MYGN | 6. mai 2024 | 19.97 | +2.57 |
MYT Netherlands Parent ADR | MYTE | 6. mai 2024 | 4.50 | +5.39 |
N-able | NABL | 6. mai 2024 | 12.71 | +1.11 |
N2OFF | NITO | 6. mai 2024 | 1.02 | 0.00 |
NaaS Technology ADR | NAAS | 6. mai 2024 | 0.92 | -1.71 |
Nabors Energy Transition II | NETDU | 6. mai 2024 | 10.55 | 0.00 |
Nabors Energy Transition II | NETD | 6. mai 2024 | 10.52 | -1.22 |
Nabors Industries | NBR | 6. mai 2024 | 74.62 | +0.53 |
NACCO Industries | NC | 6. mai 2024 | 32.53 | -2.08 |
Nano Dimension ADR | NNDM | 6. mai 2024 | 2.52 | +0.40 |
Nano Labs | NA | 6. mai 2024 | 0.57 | -9.35 |
Nano-X Imaging | NNOX | 6. mai 2024 | 9.45 | +1.12 |
Nanobiotix ADR | NBTX | 6. mai 2024 | 6.32 | +3.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.